JONESBORO, Ark. — Arkansas Progressive Medicine in Jonesboro has introduced a new therapy for adults with treatment-resistant depression, offering a non-invasive, drug-free alternative to traditional medications.
The treatment, called EXOMIND™, is an FDA-cleared device designed for adults diagnosed with Major Depressive Disorder who have not experienced adequate results from antidepressants. It uses patented Exo™TMS technology to stimulate brain regions associated with emotional regulation, cognitive function and self-control.
“This isn’t just a treatment for those who are mentally ill,” said Dr. Flippin of Arkansas Progressive Medicine. “This is about nurturing your mental health and handling the daily stresses of life.”
Mental health issues have become increasingly common. According to the National Institute of Mental Health, more than 20% of U.S. adults experienced a mental illness in 2019-2020, a figure that rose to over 23% by 2022.
EXOMIND™ sessions last less than 30 minutes and do not require sedation or recovery time. Patients typically describe the sensation as light tapping on the head. The company says patients can resume normal activities immediately after treatment.
Marketed as a therapy that integrates easily into daily routines, EXOMIND™ is aimed at patients with depression who have not responded to medication. While the company reports minimal risks, patients are advised to consult with a provider before beginning treatment.
“EXOMIND™ is more than just a device,” Flippin said. “It represents a shift in how we approach mental wellness in our clinic. This therapy provides patients with a comfortable, drug-free option to manage their mental health.”
In a testimonial shared by the company, a patient identified as Jennifer from Phoenix said she began to feel “happiness” and “joy” return after undergoing the treatment.
Although the company has not released data from large-scale clinical trials, it emphasizes that EXOMIND™ is intended to supplement — not replace — traditional mental health treatments.
Treatment is typically administered once a week for six weeks. The device may also be used to address other behavioral concerns, including overeating and nicotine addiction.
For more information or to schedule a consultation, visit arkansasprogressivemedicine.net or call (870) 520-6007.
Discover more from NEA Report
Subscribe to get the latest posts sent to your email.







Be the first to comment